Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: Targeted Therapy With or Without Nephrectomy in Metastatic Renal Cell Carcinoma: Liquid Biopsy for Biomarkers Discovery [Phase 3]
Phase 3 trial investigating targeted therapy with or without nephrectomy in metastatic clear-cell renal cell carcinoma; study terminated.
-
CLINICAL_TRIALS trial_result · 2018-11-09Clinical Trial Update: A Study of Anti-PD-1 Combinations of D-CIK Immunotherapy and Axitinib in Advanced Ranal Carcinoma [Phase 2]
Phase 2 trial investigating anti-PD-1 combinations of D-CIK immunotherapy with axitinib in metastatic renal cancer.
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: Nivolumab Combined With Ipilimumab Versus Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (CheckMate 214) [Phase 3]
Phase 3 CheckMate 214 compared nivolumab plus ipilimumab versus sunitinib in previously untreated advanced or metastatic renal cell carcinom…
-
CLINICAL_TRIALS trial_result · 2018-10-12Clinical Trial Update: Personalized Targeted Inhibitors Treatment in Renal Cell Cancer [Phase 2]
A Phase 2 clinical trial evaluating personalized targeted inhibitors for renal cell carcinoma was terminated; results were posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-10-03Clinical Trial Update: A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC) [Phase 3]
Phase 3 trial comparing atezolizumab plus bevacizumab against sunitinib in untreated advanced renal cell carcinoma has completed with result…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-09-12Clinical Trial Update: Pazopanib Hydrochloride Before Surgery in Treating Patients With Kidney Cancer [Phase 2]
Phase 2 trial evaluating pazopanib hydrochloride given before surgery in patients with renal cell carcinoma has completed with posted result…
-
CLINICAL_TRIALS trial_result · 2018-08-10Clinical Trial Update: Combined Alternating Sunitinib and Bevacizumab (Avastin®) in Advanced Renal Cell Carcinoma (CASA) [Phase 1, Phase 2]
A combined alternating regimen of sunitinib and bevacizumab is being investigated in Phase 1/2 for advanced renal cell carcinoma in a clinic…
-
CLINICAL_TRIALS trial_result · 2018-07-16Clinical Trial Update: Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney Cancer [Phase 2]
Phase 2 trial evaluating gemcitabine plus irinotecan in locally advanced unresectable or metastatic renal cell carcinoma was terminated; res…
-
CLINICAL_TRIALS trial_result · 2018-07-12Clinical Trial Update: PEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer [Phase 2]
A Phase 2 trial evaluating pegylated interferon alfa-2b, sargramostim, and thalidomide in metastatic kidney cancer was terminated; results w…
-
CLINICAL_TRIALS trial_result · 2018-07-10Clinical Trial Update: Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors [Phase 1]
Phase 1 study of nintedanib plus bevacizumab in advanced solid tumors has completed, assessing safety and preliminary activity across severa…
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Intraoperative Imagery of Renal Nodules With Folate-fluorescein Conjugate(EC17) [EARLY_Phase 1]
A Phase 1 study evaluating intraoperative imaging of renal nodules in renal cell carcinoma using the folate-fluorescein conjugate EC17; the …
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: APN401 in Treating Patients With Melanoma, Kidney Cancer, Pancreatic Cancer, or Other Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery [Phase 1]
Phase 1 trial evaluating APN401 in patients with metastatic or unresectable melanoma, pancreatic cancer, renal cell carcinoma, and other sol…
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: A Rollover Protocol for Subjects Previously Treated With AGS-003 [Phase 2]
This clinical trial update notes a rollover protocol for previously treated subjects in a Phase 2 study of AGS-003 for renal cell carcinoma,…
-
CLINICAL_TRIALS trial_result · 2018-06-26Clinical Trial Update: Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Phase 2 clinical trial evaluating bevacizumab with or without TRC105 in metastatic kidney cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-06-26Clinical Trial Update: A Phase II Study to Evaluate the Efficacy and Safety of TLC388 in Advanced/Metastatic RCC Patients [Phase 2]
A Phase II study evaluating the efficacy and safety of TLC388 in patients with advanced/metastatic renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-26Clinical Trial Update: A Prospective Study on Sunitinib as First Line Therapy for Advanced/Metastatic Renal Cell Carcinoma in Asian Population [Phase 2]
A Phase 2 trial evaluating first-line sunitinib for advanced or metastatic Renal Cell Carcinoma in Asian patients was terminated.
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: Study of IMO-2055 in Metastatic or Locally Recurrent Clear Cell Renal Carcinoma [Phase 2]
Phase 2 study evaluating IMO-2055 for metastatic or locally recurrent clear cell renal cell carcinoma has completed and results are posted.
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: Nexavar Post-marketing Surveillance for Renal Cell Carcinoma in Japan
A post-marketing surveillance study of sorafenib (Nexavar) for renal cell carcinoma in Japan has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: Nexavar Post-marketing Surveillance for RCC in Japan: Early Access Program
Sorafenib (Nexavar) underwent post-marketing surveillance for renal cell carcinoma in Japan under an Early Access Program and the program ha…
-
CLINICAL_TRIALS trial_result · 2018-05-07Clinical Trial Update: A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric Cancers [Phase 2]
Phase 2 clinical trial evaluating tasquinimod in advanced/metastatic hepatocellular, ovarian, renal cell, and gastric cancers has been compl…
-
CLINICAL_TRIALS trial_result · 2018-05-04Clinical Trial Update: Fosaprepitant for N/V With High-dose Interleukin-2 for Metastatic Melanoma and Renal Cell Carcinoma [Phase 2]
Phase 2 trial of fosaprepitant for preventing chemotherapy-related nausea and vomiting in patients receiving high-dose interleukin-2 for met…
-
CLINICAL_TRIALS trial_result · 2018-05-03Clinical Trial Update: A Study of Famitinib in Patients With Advanced Metastatic Renal Cell Cancer [Phase 2]
Phase 2 study of famitinib in advanced/metastatic renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-30Clinical Trial Update: A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer [Phase 1]
A Phase 1 study evaluating varlilumab in combination with atezolizumab in patients with advanced cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-04-26Clinical Trial Update: Validation of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Prognostic Classification for Targeted Therapies (TKI/mTOR Inhibitors) in Second Line After First Line Treatment With Pazopanib
Completed clinical trial validating the IMDC prognostic classification for second-line therapy in metastatic renal cell carcinoma after init…
-
CLINICAL_TRIALS trial_result · 2018-04-26Clinical Trial Update: Assessment of Bone Biomarkers for TKI Response in RCC With Bone Metastases, HRQoL and Comparison of Imaging Techniques
A terminated clinical trial evaluating bone biomarkers for tyrosine kinase inhibitor response in renal cell carcinoma with bone metastases, …